Quantinno Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.1M Sell
149,866
-57
-0% -$768 ﹤0.01% 1593
2025
Q4
$1.68M Buy
149,923
+81,430
+119% +$932K ﹤0.01% 1447
2025
Q3
$792K Buy
68,493
+41,281
+152% +$483K ﹤0.01% 1636
2025
Q2
$333K Buy
27,212
+15,479
+132% +$195K ﹤0.01% 1944
2025
Q1
$168K Buy
+11,733
New +$183K ﹤0.01% 1928
2020
Q4
Sell
-15,368
Closed -$511K 338
2020
Q3
$511K Buy
+15,368
New +$491K 0.34% 107

Other funds holding AVNS

Quantinno Capital Management's AVNS Position: Q1 2026 in Review

Quantinno Capital Management reduced its Avanos Medical (AVNS) stake by 0.04% in Q1 2026, selling an estimated $768 and leaving 149,866 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

Quantinno Capital Management first reported a position in AVNS in Q3 2020 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Quantinno Capital Management held 149,866 shares of Avanos Medical worth $2.1M as of Q1 2026.
  • Quantinno Capital Management sold 57 Avanos Medical shares in Q1 2026, an estimated $768.
  • Avanos Medical made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1593 holding.
  • Quantinno Capital Management first reported a position in Avanos Medical in Q3 2020 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.